We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Co., Investors Win OK For $3.4M Stock Drop Deal

Law360, New York (October 4, 2017, 5:28 PM EDT) -- A California federal judge has approved a $3.4 million deal to end a stock drop suit between Ampio Pharmaceuticals Inc. and investors over allegations that the company misled investors about a drug trial for its osteoarthritis treatment.

U.S. District Judge Terry J. Hatter Jr. granted final approval to the $3.4 million deal after initially rejecting a preliminary bid in February. The settlement covers all investors who bought Ampio stock from January to August 2014, with the company not admitting liability. Class counsel from The Rosen Law...
To view the full article, register now.




Case Information

Case Title

Guidano Napoli v. Ampio Pharmaceuticals, Inc. et al

Case Number



California Central

Nature of Suit



Terry J. Hatter, Jr

Date Filed

May 8, 2015

Law Firms

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.